CNS Pharmaceuticals prices $3M registered direct offering of common stock and pre-funded warrants at $0.17/share

CNS Pharmaceuticals, Inc.

Gross proceeds ~$3M from sale of 3.7M common shares and pre-funded warrants for 13.9M shares at $0.17/share.
A.G.P./Alliance Global Partners acting as sole placement agent; receives 6.5% fee plus up to $90k expenses.
Closing expected Oct 24, 2024; proceeds for working capital and general corporate purposes.
After partial exercise of pre-funded warrants, company now has 49,574,933 shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.